Robin Gradin
Medicon Village
Lund, M 22381, Sweden
Lund, M 22381, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
RNA-Seq Can Be Used to Quantify Gene Expression Levels for Use in the GARDskin Assay.
Journal: Toxics
Published: September 25, 2025
GARDskin dose-response assay and its application in conducting Quantitative Risk Assessment (QRA) for fragrance materials using a Next Generation Risk Assessment (NGRA) framework.
Journal: Regulatory toxicology and pharmacology : RTP
Published: December 14, 2023
GARD™skin and GARD™potency: A proof-of-concept study investigating applicability domain for agrochemical formulations.
Journal: Regulatory toxicology and pharmacology : RTP
Published: November 24, 2023
The GARD™skin assay: Investigation of the applicability domain for metals.
Journal: ALTEX
Published: March 02, 2022
Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin.
Journal: Scientific reports
Published: June 04, 2021
The GARDpotency Assay for Potency-Associated Subclassification of Chemical Skin Sensitizers-Rationale, Method Development, and Ring Trial Results of Predictive Performance and Reproducibility.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: May 19, 2020
Validation of the GARD™skin Assay for Assessment of Chemical Skin Sensitizers: Ring Trial Results of Predictive Performance and Reproducibility.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: May 18, 2019
Skin Sensitization: Challenging the Conventional Thinking-A Case Against 2 Out of 3 as Integrated Testing Strategy.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: June 22, 2017
Last Updated: 09/26/2026